🧬 Interested in pharma, biotech and medical device news? Visit PharmaDeviceNews.com →
Browsing Tag

United States

1071 posts
Read More

Swarmer (SWMR) moves into combat drone hardware with Vataga IP deal as revenue scale remains unproven

Nasdaq-listed Swarmer has signed an agreement to acquire selected intellectual property from Ukrainian drone manufacturer Vataga and bring 15 members of its leadership and engineering team into the business. The transaction extends Swarmer beyond software into hardware design and integration while raising questions about financing, dilution and its ability to convert battlefield deployments into recurring revenue.
Read More

Octant’s OCT-980 gains FDA orphan status, but can an oral molecule slow inherited vision loss?

Octant has received FDA orphan drug designation for OCT-980, an investigational oral therapy targeting protein misfolding associated with inherited retinal degeneration. The regulatory milestone follows the first patient dosing in September and supports development of a potentially disease-modifying treatment for rhodopsin-associated autosomal dominant retinitis pigmentosa.
Infographic highlighting HoloMD's appointment of Irene Lang as CEO, Dr. Bruce Alan Kehr's transition to medical innovation, a 180-day paid pilot involving 138 patients and plans for human-supervised AI monitoring between psychiatric appointments.
Read More

HoloMD names former Eliza founder Irene Lang CEO, but can continuous AI monitoring become a scalable psychiatry business?

HoloMD has appointed Silicon Valley entrepreneur Irene Lang as chief executive officer and cofounder, moving founder Dr. Bruce Alan Kehr into a medical innovation role. The transition follows a 180-day paid pilot involving 138 patients and reflects a strategy to commercialize human-supervised AI monitoring between psychiatric appointments.
Infographic showing X-Bow Systems’ selection by CoAspire to develop and produce solid rocket booster motors for the U.S. Navy, highlighting seven propulsion programme selections in 2026 and the challenge of scaling missile component manufacturing.
Read More

X-Bow selected to supply solid rocket boosters for CoAspire’s ground-launched Navy CHAOS cruise missile

X-Bow Systems has been selected by CoAspire to develop and produce solid rocket booster motors for the U.S. Navy's Coalition Heterogeneous Affordable Offensive Strike programme. The decision expands X-Bow's role in lower-cost precision weapons after seven propulsion programme selections in 2026, while highlighting the challenge of manufacturing missile components at sustained volume.
Infographic showing MISSION-backed healthcare insurance specialist Altea’s expansion into the United States, highlighting Justin Rodrick and Chief Executive Officer Carly Matson, its focus on allied healthcare providers and smaller medical facilities, and insurance capacity through Accelerant’s Risk Exchange.
Read More

Altea appoints Justin Rodrick as vice president ahead of U.S. healthcare insurance launch in Q4 2026

MISSION-backed healthcare insurance specialist Altea is entering the United States with Justin Rodrick leading its domestic expansion alongside Chief Executive Officer Carly Matson. The business will initially target allied healthcare providers, smaller medical facilities and specialist MGA programmes, using insurance capacity accessed through Accelerant's Risk Exchange.
Infographic highlighting Guidewire’s agreement to acquire hyperexponential for $1.7 billion in cash plus up to $400 million tied to recurring revenue targets, alongside AI-assisted insurance underwriting opportunities and financing and integration challenges.
Read More

Guidewire (GWRE) to acquire hyperexponential for up to $2.1bn as AI underwriting strategy accelerates

Guidewire has agreed to acquire London-based hyperexponential for $1.7 billion in cash plus up to $400 million tied to recurring revenue targets. The insurance software group expects the transaction to accelerate annual recurring revenue growth and deepen its position in AI-assisted commercial underwriting, while introducing substantial financing and integration requirements.
Infographic showing Nova Minerals’ final Alaska approvals for its integrated antimony project, highlighting the Styx and Stibium prospects, Whiskey Bravo concentration facility, Port MacKenzie refinery, $43.4 million in U.S. government support and upcoming construction and production milestones.
Read More

Nova Minerals (NVA) secures final Alaska antimony permits as $43.4m project targets 2027 production

Nova Minerals has received final Alaska Department of Natural Resources approvals for an integrated antimony operation covering the Styx and Stibium prospects, Whiskey Bravo concentration facility and Port MacKenzie refinery. With $43.4 million in U.S. government support and major equipment delivered, construction and production execution become the next tests.
Infographic showing Dragos Public Sector’s appointment of Rob Joyce and Maria Barrett to its board, expansion of the Dragos Platform into connected devices, cloud infrastructure and software supply chains, and federal market collaboration with Accenture Federal Services.
Read More

Dragos Public Sector appoints former NSA and Army Cyber Command leaders as xOT security platform expands

Dragos Public Sector has appointed former National Security Agency cybersecurity director Rob Joyce and retired U.S. Army Cyber Command leader Maria Barrett to its board while extending the Dragos Platform across connected devices, cloud infrastructure and software supply chains. Accenture Federal Services will support federal market expansion following the parent company's recent acquisitions.